NDC 70771-1481

Rosuvastatin

Rosuvastatin

Rosuvastatin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Cadila Healthcare Limited. The primary component is Rosuvastatin Calcium.

Product ID70771-1481_493a5304-a54c-41db-80b8-b2f25f09d829
NDC70771-1481
Product TypeHuman Prescription Drug
Proprietary NameRosuvastatin
Generic NameRosuvastatin
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2020-01-16
Marketing CategoryANDA / ANDA
Application NumberANDA206513
Labeler NameCadila Healthcare Limited
Substance NameROSUVASTATIN CALCIUM
Active Ingredient Strength5 mg/1
Pharm ClassesHMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 70771-1481-0

1000 TABLET, FILM COATED in 1 BOTTLE (70771-1481-0)
Marketing Start Date2020-01-16
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 70771-1481-2 [70771148102]

Rosuvastatin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 70771-1481-1 [70771148101]

Rosuvastatin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 70771-1481-0 [70771148100]

Rosuvastatin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 70771-1481-9 [70771148109]

Rosuvastatin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 70771-1481-5 [70771148105]

Rosuvastatin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

NDC 70771-1481-3 [70771148103]

Rosuvastatin TABLET, FILM COATED
Marketing CategoryANDA
Application NumberANDA206513
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-01-16

Drug Details

Active Ingredients

IngredientStrength
ROSUVASTATIN CALCIUM5 mg/1

Pharmacological Class

  • HMG-CoA Reductase Inhibitor [EPC]
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

NDC Crossover Matching brand name "Rosuvastatin" or generic name "Rosuvastatin"

NDCBrand NameGeneric Name
16729-284RosuvastatinRosuvastatin
16729-285RosuvastatinRosuvastatin
16729-286RosuvastatinRosuvastatin
16729-287RosuvastatinRosuvastatin
31722-882RosuvastatinRosuvastatin
31722-883RosuvastatinRosuvastatin
31722-884RosuvastatinRosuvastatin
31722-885RosuvastatinRosuvastatin
49252-061ROSUVASTATINrosuvastatin
49252-062ROSUVASTATINrosuvastatin
49252-063ROSUVASTATINrosuvastatin
49252-064ROSUVASTATINrosuvastatin
50090-2722RosuvastatinRosuvastatin
50090-2723RosuvastatinRosuvastatin
69238-1148RosuvastatinRosuvastatin
69238-1146RosuvastatinRosuvastatin
69238-1147RosuvastatinRosuvastatin
69238-1149RosuvastatinRosuvastatin
70518-0986RosuvastatinRosuvastatin
70518-1219RosuvastatinRosuvastatin
70518-1601RosuvastatinRosuvastatin
70518-1384RosuvastatinRosuvastatin
71205-044RosuvastatinRosuvastatin
50090-2724RosuvastatinRosuvastatin
50090-2725RosuvastatinRosuvastatin
50268-711RosuvastatinRosuvastatin
50268-709RosuvastatinRosuvastatin
50268-710RosuvastatinRosuvastatin
55700-574RosuvastatinRosuvastatin
55700-575RosuvastatinRosuvastatin
60505-2886ROSUVASTATINROSUVASTATIN
60505-4505ROSUVASTATINROSUVASTATIN
60505-2885ROSUVASTATINROSUVASTATIN
60505-4504ROSUVASTATINROSUVASTATIN
60505-2888ROSUVASTATINROSUVASTATIN
60505-2887ROSUVASTATINROSUVASTATIN
60505-4503ROSUVASTATINROSUVASTATIN
60505-4502ROSUVASTATINROSUVASTATIN
61919-786RosuvastatinRosuvastatin
50228-116RosuvastatinRosuvastatin
50228-117RosuvastatinRosuvastatin
50228-119RosuvastatinRosuvastatin
50228-118RosuvastatinRosuvastatin
47335-984EZALLOR SPRINKLEROSUVASTATIN
47335-985EZALLOR SPRINKLEROSUVASTATIN
47335-986EZALLOR SPRINKLEROSUVASTATIN
47335-987EZALLOR SPRINKLEROSUVASTATIN
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.